Taken together, these results indicate that ECM-degrading enzymes, that is, MMPs and ADAM-17, worsen the functional disturbance after stroke by promoting deconstruction of the blood-brain barrier and infiltration of the inflammatory cells. The gene discussed is ADAM17; the disease is stroke disorder.